Shigella News and Research

RSS

Finland joins international organization dedicated to COVID-19 vaccines

The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country's accession to IVI.

11 Aug 2020

UTSW researchers show how vulnerable cells armor themselves against infection

Cells in some of the body's most vulnerable entry routes to bacterial infection buffer themselves when the immune system detects danger by reorganizing the cholesterol on their surfaces, a new study led by UTSW scientists suggests.

13 Apr 2020

A joint effort to confront the challenges of rising antimicrobial resistance in Asia

The International Vaccine Institute (IVI) and the Technical University of Denmark's (DTU) National Food Institute announced today a joint effort to strengthen external quality assurance programs for diagnostic laboratories in Asia to confront the challenges of rising antimicrobial resistance (AMR) in the region.

6 Mar 2020

"State of the Nation" report on STIs in England released

Two sexually transmitted infection (STI) charity organizations - British Association for Sexual Health and HIV and Terrance Higgins Trust have released a “State of The Nation” Report on STIs in England. This new report reveals the actual status of STIs in the nation and the steps that administration could take to bring down the numbers.

6 Feb 2020

Sida continues to support IVI’s mission to accelerate vaccine research

The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.

13 Jan 2020

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age.

9 Jan 2020

Certain bacteria can override programmed cell death

Certain bacteria can override a defense mechanism of the immune system, so called programmed cell death, through inhibition of death effector molecules by their outer membranes components.

26 Dec 2019

Antibiotic-resistant shigella strain cases soar in Australia

A drug-resistant strain of a highly contagious sexually-transmitted bowel infection spreads in Victoria, Australia, with a vast majority of cases happening in men who have sex with men.

19 Dec 2019

UMSOM researchers to test the safety, tolerability of prototype Shigella-ETEC vaccine

Each year, millions of people contract serious diarrheal illnesses typically from contaminated food and water. Among the biggest causes of diarrheal diseases are the bacteria Shigella and enterotoxigenic Escherichia coli, and researchers at the University of Maryland School of Medicine are testing a vaccine designed to offer protection against these serious pathogens.

10 Dec 2019

Early adherence step in intestinal transit of Shigella discovered

The bacterial pathogen Shigella, often spread through contaminated food or water, is a leading cause of mortality in both children and older adults in the developing world.

4 Dec 2019

Abnormal gut bacteria linked to poor cognitive performance in vets with PTSD and cirrhosis

A study involving military veterans with PTSD and cirrhosis of the liver points to an abnormal mix of bacteria in the intestines as a possible driver of poor cognitive performance--and as a potential target for therapy.

13 Sep 2019

UVA scientists reveal how E. coli knows to cause the worst possible infections

A pair of University of Virginia School of Medicine scientists have revealed how E. coli seeks out the most oxygen-free crevices of your colon to cause the worst infection possible.

19 Aug 2019

Research shows how E. coli knows where and when to begin colonizing the colon

A pair of University of Virginia School of Medicine scientists have revealed how E. coli seeks out the most oxygen-free crevices of your colon to cause the worst infection possible.

19 Aug 2019

Whole genome sequencing could give officials a powerful weapon to track disease outbreaks

Whole genome sequencing technology may give epidemiologists and healthcare workers a powerful weapon in tracking and, possibly, controlling outbreaks of serious diseases, according to a team of researchers.

8 Aug 2019

Organic apples have probiotic properties

A new study shows that eating an apple, core and all, is the equivalent of eating not only fiber, vitamins and, sugars, but also about 100 million bacteria.

29 Jul 2019

Swimming pools could be breeding grounds for diarrhea-causing germs

Summers get along best with swimming pools, spas and other water play regions. The Centre for Disease Prevention and Control (CDC) USA has warned that these pools could be the focal point of spread of certain bacteria, parasites and virsues.

1 Jul 2019

Antibiotic susceptibility pattern of Enterobacteriaceae found in Ghana

Passing on dangerous naked explosives: the state of multiple antibiotic resistant Enterobacteriaceae in Cape Coast, Ghana.

29 Jun 2019

Autophagy can help combat Salmonella and other pathogens

Autophagy - the process of recycling cellular material in the body, can help combat Salmonella and other pathogens according to researchers at the School of Life Sciences, University of Warwick who have studied how autophagy can get rid of bacteria, and prevent diseases developing.

27 Mar 2019

Fluctuating growth rate of bacteria helps it to develop resistance against antibiotic

If an antibiotic doesn't kill all the bacteria that infects a patient, the surviving bugs may be particularly adept at timing their resurgence.

22 Mar 2019

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

28 Jan 2019